Ozelle to Launch O-Cyte 1 at ADLM 2026 for Enhanced Hematology Analysis Using AI Technology
Ozelle is set to introduce its cutting-edge automated hematology analyzer, O-Cyte 1, at the upcoming ADLM 2026 event in Anaheim, California. This marks a significant milestone in the integration of artificial intelligence within the field of hematology. O-Cyte 1 is designed to enhance the performance and scalability of hematological analysis, moving beyond traditional numeric data to provide comprehensive morphological insights through advanced imaging techniques.
Historically, cellular morphology has served as a critical source of hematological information. However, the challenge has been integrating this visual data into high-volume workflows without compromising productivity. Manual microscopy requires specialized skills that are not always readily available, while image-based systems have struggled to seamlessly fit within the fast-paced environment of modern laboratories.
O-Cyte 1 tackles these challenges head-on by combining sophisticated morphological intelligence, robust performance, and user-friendly operation in a compact design. Utilizing Ozelle's innovative AI × CBM (Complete Blood Morphology) technology, this analyzer converts cellular images into structured morphological data, enabling a workflow that leverages visual evidence for clearer interpretations.
With its ability to process up to 60 tests per hour as a stand-alone unit and up to 360 tests per hour when cascaded, O-Cyte 1 is tailored for productivity in clinical settings. Its compact size, modular architecture, low-maintenance workflow, and service-ready design are specifically aimed at helping healthcare professionals and lab operators enhance efficiency while minimizing operational complexity.
"O-Cyte 1 epitomizes our vision of making advanced morphological intelligence more practical, scalable, and accessible for routine hematology workflows," stated Raymond, head of Ozelle's North American division. "At ADLM, we look forward to demonstrating to our global partners how AI-driven morphology can be integrated into more productive hematological workflows."
At ADLM 2026, Ozelle will showcase O-Cyte 1 alongside its clinical hematology product portfolio. With the rising need for efficient and scalable hematology solutions across North America, Europe, the Middle East, Southeast Asia, India, and beyond, Ozelle aims to support various clinical environments with AI-powered diagnostic systems tailored for everyday practice.
Visitors and partners are invited to experience O-Cyte 1 at Booth 2517 during ADLM 2026, taking place from July 28 to 30 at the Anaheim Convention Center. Partners unable to attend in person can also request a product demonstration and explore regional collaboration opportunities. For more information, visit Ozelle's website at www.ozellemed.com or contact them via email at [email protected]
Historically, cellular morphology has served as a critical source of hematological information. However, the challenge has been integrating this visual data into high-volume workflows without compromising productivity. Manual microscopy requires specialized skills that are not always readily available, while image-based systems have struggled to seamlessly fit within the fast-paced environment of modern laboratories.
O-Cyte 1 tackles these challenges head-on by combining sophisticated morphological intelligence, robust performance, and user-friendly operation in a compact design. Utilizing Ozelle's innovative AI × CBM (Complete Blood Morphology) technology, this analyzer converts cellular images into structured morphological data, enabling a workflow that leverages visual evidence for clearer interpretations.
With its ability to process up to 60 tests per hour as a stand-alone unit and up to 360 tests per hour when cascaded, O-Cyte 1 is tailored for productivity in clinical settings. Its compact size, modular architecture, low-maintenance workflow, and service-ready design are specifically aimed at helping healthcare professionals and lab operators enhance efficiency while minimizing operational complexity.
"O-Cyte 1 epitomizes our vision of making advanced morphological intelligence more practical, scalable, and accessible for routine hematology workflows," stated Raymond, head of Ozelle's North American division. "At ADLM, we look forward to demonstrating to our global partners how AI-driven morphology can be integrated into more productive hematological workflows."
At ADLM 2026, Ozelle will showcase O-Cyte 1 alongside its clinical hematology product portfolio. With the rising need for efficient and scalable hematology solutions across North America, Europe, the Middle East, Southeast Asia, India, and beyond, Ozelle aims to support various clinical environments with AI-powered diagnostic systems tailored for everyday practice.
Visitors and partners are invited to experience O-Cyte 1 at Booth 2517 during ADLM 2026, taking place from July 28 to 30 at the Anaheim Convention Center. Partners unable to attend in person can also request a product demonstration and explore regional collaboration opportunities. For more information, visit Ozelle's website at www.ozellemed.com or contact them via email at [email protected]
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.